Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Orexo completes dose proportionality study of opioid dependence drug

June 19, 2012

Cleveland BioLabs reports survival results with CBLB-502

June 5, 2012

Phase IIb trial of Catalyst's treatment candidate for cocaine addiction reaches target enrollment

May 22, 2012

NIDA grant supports Scripps Research Institute smoking cessation research

May 16, 2012

Vanda Pharmaceuticals acquires tachykinin NK1 receptor antagonist

April 17, 2012

New vaccine shows promise to treat drug addiction

April 13, 2012

Nippon Shinyaku seeks approval of drug for persons with alcohol dependence

March 27, 2012

NME protects human bone marrow progenitor cells against radiation

March 15, 2012

Immunovaccine and Weill Cornell Medical College join to develop anticocaine vaccine

March 13, 2012

Researchers in U.S. design new therapeutics for radiation injury

March 9, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...